Clinical trials
Hypertension, Pulmonary trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 9 |
| 2010 | 6 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Terminated | 12 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Enrolling by invitation | 2 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Graz | 17 |
| Bayer | 10 |
| United Therapeutics | 7 |
| Actelion | 3 |
| Gilead Sciences | 2 |
| Medical University of Vienna | 2 |
| Novartis Pharmaceuticals | 2 |
| Abbott Medical Devices | 1 |
| Aria CV, Inc | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 60 |
| Pulmonary Arterial Hypertension | 17 |
| Cardiovascular Diseases | 3 |
| Familial Primary Pulmonary Hypertension | 3 |
| Heart Failure | 3 |
| Lung Diseases | 3 |
| Respiratory Tract Diseases | 3 |
| Scleroderma, Systemic | 3 |
| Vascular Diseases | 3 |
| Connective Tissue Diseases | 2 |
Trials
Showing 26 to 50 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.